Gainers
-
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shares gained 46.4 percent to $14.495 after announcing positive Phase 2b
results for its topical ocular reproxalap in patients with dry eye disease.
-
India Globalization Capital, Inc. (NYSE: IGC) shares climbed 28.8 percent to $3.00 after the company late Tuesday won an
agreement for global rights to develop CBD-infused drinks.
-
Onconova Therapeutics, Inc. (NASDAQ: ONTX) gained 19.6 percent to $9.53.
-
Electromed, Inc. (NYSE: ELMD) shares
gained 19.3 percent to $6.56 following Q4 results. Electromed posted Q4 earnings of $0.13 per share on sales of $8.2 million.
-
Oasmia Pharmaceutical AB (NASDAQ: OASM) shares surged 13.8 percent to $5.29.
-
Obalon Therapeutics, Inc. (NASDAQ: OBLN) gained 12.5 percent to $2.88 after announcing approval of a Premarket
Approval Supplement (PMA-S) application for the Obalon Touch™ Inflation System.
-
Anavex Life Sciences Corp. (NASDAQ: AVXL) surged 11.4 percent to $3.04.
-
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) rose 9.3 percent to $22.575. Vanda Pharmaceuticals will replace Inogen
in the S&P SmallCap 600 on Monday, October 1.
-
Canada Goose Holdings Inc (NYSE: GOOS)
rose 9.3 percent to $63.39 after DA Davidson initiated coverage on the stock with a Buy rating and $68 price target.
-
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) gained 8.4 percent to $3.415.
-
GoPro, Inc. (NASDAQ: GPRO) shares rose
6.8 percent to $7.07. Oppenheimer upgraded GoPro from Perform to Outperform.
-
Papa John's Int'l, Inc. (NASDAQ: PZZA)
rose 5.4 percent to $48.72 following Bloomberg report that the founder Is reaching out to PE firms related to a possible deal.
-
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) rose 5.2 percent to $135.74 after the company earlier announced it will
acquire Syntimmune for $400 million up front and up to $800 million in potential milestones.
-
VAALCO Energy, Inc. (NYSE: EGY) rose 4.3
percent to $2.70 after the company received a 10-year extension of three Exclusive Exploitation Authorizations under the Etame
PSC.
-
Verastem, Inc. (NASDAQ: VSTM) rose 3.8
percent to $7.4201 after announcing the signing of an exclusive license agreement for the development and commercialization of
COPIKTRA in China. The company will receive an upfront payment of $15 million and will be eligible for up to $30 million in
milestones.
-
AAR Corp. (NYSE: AIR) rose 3.4 percent to
$47.56 after reporting better-than-expected results for its first quarter.
Check out these big penny stock gainers and
losers
Losers
-
Level Brands, Inc. (NYSE: LEVB) shares
fell 24.3 percent to $3.975.
-
Digital Ally, Inc. (NASDAQ: DGLY)
shares dipped 15.5 percent to $3.00. Digital Ally priced its 2.4 million share offering at $3.05 per share.
-
Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) shares declined 13.2 percent to $13.02. Entasis Therapeutics priced its
upsized offering of 5 million shares at $15, below the estimated price range of $16 to $18.
-
CPI Card Group Inc. (NASDAQ: PMTS)
shares fell 9.7 percent to $3.30.
-
Pioneer Energy Services Corp. (NYSE: PES)
shares declined 9.6 percent to $3.075 after the company lowered its forecast for international drilling utilization.
-
Aceto Corporation (NASDAQ: ACET)
dropped 9.2 percent to $2.57. Garrett Motion Inc. will replace Aceto in the S&P SmallCap 600 on Tuesday, October 2.
-
PolarityTE, Inc (NASDAQ: PTE) shares
fell 8.6 percent to $19.30 as traders circulate negative comments from Capitol Forum. The firm said PolarityTE's form 483
raised issues with SkinTE processing.
-
NextDecade Corporation (NASDAQ: NEXT)
shares declined 8.5 percent to $5.05.
-
Worthington Industries, Inc. (NYSE: WOR)
shares fell 8.2 percent to $42.61 after the company missed Q1 earnings estimates.
-
Nightstar Therapeutics plc (NASDAQ: NITE) fell 8 percent to $18.81 after reporting a 4 million ADS offering.
-
Chegg Inc (NYSE: CHGG) dropped 7.9
percent to $29.80. The company late Tuesday reaffirmed Q3 sales guidance, which was near the lower end of estimates.
-
Actuant Corporation (NYSE: ATU) dropped
6.6 percent to $27.80. Actuant posted upbeat results for its fourth quarter, but issued a weak profit forecast.
-
Cintas Corporation (NASDAQ: CTAS) fell
5.3 percent to $201.8205. Cintas reported upbeat earnings for its first quarter and raised FY19 guidance.
-
CyrusOne Inc. (NASDAQ: CONE) fell 4.3
percent to $61.88. CyrusOne priced its 8 million shares offering at $62 per share.
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.